• OPEN AN ACCOUNT
Indian Indices
Nifty
25,959.50 -108.65
(-0.42%)
Sensex
84,900.71 -331.21
( -0.39%)
Bank Nifty
58,835.35 -32.35
( -0.05%)
Nifty IT
37,037.95 152.60
( 0.41%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,569.96 30.25
(0.32%)
Forex
USD-INR
88.67 0.16
(0.19%)
EUR-INR
102.19 -0.14
(-0.14%)
GBP-INR
115.88 -0.12
(-0.10%)
JPY-INR
0.56 0.00
(-0.65%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
41.47
819.05
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.11
 

national st&ard (india) ltd
Vistar Amar reports standalone net profit of Rs 1.03 crore in the June 2025 quarter
Aug 13,2025
Net profit of Vistar Amar reported to Rs 1.03 crore in the quarter ended June 2025. There were no net profit/loss reported during the previous quarter ended June 2024. Sales rose 139.53% to Rs 27.33 crore in the quarter ended June 2025 as against Rs 11.41 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales27.3311.41 140
OPM %8.120.88 -
PBDT2.180.08 2625
PBT1.560 0
NP1.030 0